Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: A randomized, double-blind, placebo-controlled trial

Journal of the American College of Nutrition

Volumn 16, Issue 3, 1997, Pages 236-243

  Davidson, Michael H ^a   Maki, Kevin C ^a   Kalkowski, Joann ^a   Schaefer, Ernst J ^b   Torri, Sarah A ^a   Drennan, Kathleen B ^a  

^a RADIANT RESEARCH   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Docosahexaenoic acid; Hyperlipidemia; Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CAPSULE FILLING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL AVAILABILITY; CHOLESTEROL; DIET; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 0031000402     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1997.10718680     Document Type: Article

References (21)

1. DavidsonMH, LiebsonPR: Marine lipids and atherosclerosis: a review. Cardiovascular Reviews & Reports7:461-472, 1986.
2. WeinerHH, OckenIS, LevinePH, CuenoudHF, FischerM, JohsonBF, DaoudAS, JarrnolychJ, HosmerD, JohsonMH, NataleA, VaudreuilC.Hoogasaian JJ: Inhibition of atherosclerosis by cod liver oil in a hyperlipidemic swine model. N Engl J Med314:841-845, 1986.
3. DavidsonMH, BumsJH, SubbaiahPV, ConnME, DrennanK: Marine oil capsule therapy for the treatment of hyperlipidemia. Arch Intern Med151:1732-1740, 1991.
4. HanisWH, DujovneCA, ZuckerM, JohnsonB: Effects of a low saturated fat, low cholesterol fish oil Supplement in hypertriglyceridemia subjects. Ann Intern Med109:465-470, 1988.
5. SalemN, KimH-Y, YergeyJA: Docosahexaenoic Acid: Membrane Function and Metabolism. In Simopolous A, Kifer RR, Martin RE (eds): "Health Effects of Polyunsaturated Fatly Acids in Seafoods." Orlando: Academic Press, pp 263-318, 1986.
6. KyleOJ, SicotteVJ, SingerJJ, ReebSE: Bioproduction of docosahexaenoic acid (DHA) by microalgae. In DJ Kyle C Ratledge (eds): "Industrial Applications of Single Cell Oils." Champaign: Amer. Oil Chern. Soc. Press, 1992.
7. SchackyCV, WeberPC: Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest76:2446-2450, 1985.
8. YoshikiK, KurodaK, JinnouchiH, NishideE, InnamiS: Differential effects of dietary eicosapentaenoic and docosahexaenoic fatty acids on lowering of triglyceride and cholesterol levels in the serum of rats on hypercholesterolemic diet. J Nutr Sci Vitamin30:357-372, 1984.
9. Conquer JA, Holub BJ: Effect ofSupplementation withan algae source of docosahexaenoic acid on omega-3 status and risk factors for heart disease in vegetarian subjects. J Nutr, in press.
10. Agren JJ, Hanninen O, Julkunen A, Fogelholm L, Maliranta H, Schwab U, Pynnonen O, Uusitupa M: Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Nutr, in press.
11. FriedewaldWT, LevyRI, FredricksonDS: Estimation of LDLcholesterol in plasma without use of the preoperative ultracentrifuge. Clin Chern18:499-502, 1972.
12. MeydaniSN, LichtensteinAH, CornwallS, MeydaniM, GoldinBR. RasmussenH, DinarelloCA, SchaeferEJ: Immunological effects of National Cholesterol Education Panel Step II diets with and without fish-derived n-3 fatly acid enrichment. J Clin Invest92:105-113,1993.
13. RadackKL, DeckCC, HusterGA: N-3 fatty acid effects on lipids, lipoproteins, and apolipoproteins at very low doses: Results of a randomized controlled trial in hypertriglyceridemic subjects. Am J Clin Nutr51:599-605, 1990.
14. HanisWS, RothrockDW, FanningA, InkelesSB, GoodnightSH, IllingworthRD, ConnorWE: Fish oils in hypertriglyceridemia: a dose-response study. Am J Clin Nutr51:399-406, 1990.
15. GrundtH, NilsenDWT, Hetland O, Aarsland T, Baksaas I, Grande T, Woie L: Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidemia. J Intern Med237:249-259, 1995.
16. KinsellaIE, LokeshB, StoneRA: Dietary n-3 fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr52:1-28, 1990.
17. MensinkRP, KatanMB: Effect of dietary fatly acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb12:911-919, 1992.
18. AssmannG, SchulteH: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70:733-737, 1992.
19. DrexelH, AmannFW, BeranJ, RentschK, CandinasR, MuntwylerJ, LeuthyA.GasserT, FollathF: Plasma triglycerides and three lipoprotein cholesterol fractions are independent risk factors of the extent of coronary atherosclerosis. Circulation 90:2233-2235, 1994.
20. SharrettAR, PatschW, SorliePD, HeissG, BondMG, DavisCE: Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb14:1098-1104, 1994.
21. TenkanenL, PietilaK, ManninenV, ManttariM: The triglyceride issue revisited. Findings from the Helsinki Heart Study. Arch Intern Med154:2714-2720, 1994.